Busulfan and Fludarabine

DRUG2 trials

Sponsors

Medical College of Wisconsin

Conditions

HIVLeukemiaLeukemia, Myelocytic, AcuteLymphoma

Phase 2

Allogeneic Transplant in HIV Patients (BMT CTN 0903)

CompletedNCT01410344

Medical College of WisconsinHIV, Leukemia, Lymphoma

Start: 2011-09-30End: 2018-06-30Updated: 2022-12-08

Phase 3

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

TerminatedNCT01339910

Medical College of WisconsinLeukemia, Myelocytic, Acute

Start: 2011-06-30End: 2017-10-16Updated: 2023-01-04

Related Papers

Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.

2019-07-0428 citations

Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial.

Journal of Clinical Oncology2017-05-2012 citations